Adhesion-prevention effects of fibrin sealants after laparoscopic myornectomy as determined by second-look laparoscopy - A prospective, randomized, controlled study

被引:0
|
作者
Takeuchi, H [1 ]
Kitade, M [1 ]
Kikuchi, I [1 ]
Shimanuki, H [1 ]
Kumakiri, J [1 ]
Kinoshita, K [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138421, Japan
关键词
adhesions; laparoscopic surgical procedures; fibrin sealant; myomectomy;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To examine the adhesion prevention effects of 2 types of fibrin sealant after laparoscopic myomectomy (LM). STUDY DESIGN: A prospective, randomized study (Canadian Task Force 1) was conducted at a University-affiliated hospital. A total of 91 patients showing a minimal myoma > 5 cm, excluding pedunculated myomas, underwent LM alone: 32 patients in the control group, 29 in the fibrin gel group and 30 patients in the fibrin sheet. group. After LM, postoperative adhesions were evaluated by second-look laparoscopy. The frequency of postoperative adhesions was the main. outcome. RESULTS: The frequency of postoperative adhesions of the uterus was significantly lower (p < 0.05) in the fibrin gel group, with 20132 (62.5%) in the control group, 10129 (34.5%) in the fibrin gel group and 20130 (67.7%) in the fibrin sheet group. Although no significant differences were found in the incidence of de novo adnexal adhesions, the lowest rate was found in the fibrin gel group, with 4132 patients (12.5%) in the control group, 2129 patients (6.8%) in the fibrin gel group and 5130 patients (16.7%) in the fibrin sheet group. No bilateral adnexal adhesions were observed in the 3 groups. CONCLUSION: After LM for myomas as large as >= 5 cm, postoperative adhesions were observed in >= 50% of patients. The use of fibrin gel after LM is recommended.
引用
收藏
页码:571 / 577
页数:7
相关论文
共 1 条
  • [1] Fibrin sealant for the prevention of anastomotic leakage after esophagectomy for esophageal or esophagogastric junction cancer: interim report of a prospective, phase III, randomized controlled study
    Zerui Zhao
    Zhichao Li
    Weizhao Huang
    Geng Wang
    Teng Mao
    Wenqiang Lv
    Lin Peng
    Jiyang Chen
    Hong Yang
    Holistic Integrative Oncology, 2 (1):